Oxidative Stress in Lung Cancer

Cancer: Oxidative Stress and Dietary Antioxidants

Volumn , Issue , 2014, Pages 23-32

  Joshua Loke, Wei Sheng ^a,b   Lim, Mann Ying ^a,b   Lewis, Craig R ^b   Thomas, Paul S ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Etiology; Inflammation; Lung cancer; Oxidative stress; RNS; ROS

Indexed keywords

EID: 84902055884     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405205-5.00003-9     Document Type: Chapter

References (60)

1. D'Amato G., Liccardi G., D'Amato M., Cazzola M. Respiratory allergic diseases induced by outdoor air pollution in urban areas. Monaldi Archives for Chest Disease 2002, 57:161-163.
2. Schwela D. Air pollution and health in urban areas. Rev Environ Health 2000, 15:13-42.
3. Li X., Fang P., Mai J., Choi E.T., Wang H., Yang X.F. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol 2013, 19.
4. Araneda O.F., Tuesta M. Lung oxidative damage by hypoxia. Oxid Med Cell Longevity 2012.
5. Gould N.S., Min E., Gauthier S., Chu H.W., Martin R., Day B.J. Aging adversely affects the cigarette smoke-induced glutathione adaptive response in the lung. Am J Respir Crit Care Med 2010, 182:1114-1122.
6. Federico A., Morgillo F., Tuccillo C., Ciardiello F., Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007, 121:2381-2386.
7. National Lung Screening Trial Research Team Aberle D.R., Adams A.M., Berg C.D., Black W.C., Clapp J.D., Fagerstrom R.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409.
8. Parkin M., Tyczynski J.E., Boffetta P., Samet J., Shields P., Caporaso N. Tumours of the lung. Pathology and genetics of tumours of the lung 2004, 12-15. WHO Publications Center. W.D.B.E. Travis, H.K. Müller-Hermelink, C.C. Harris (Eds.).
9. Couraud S., Zalcman G., Milleron B., Morin F., Souquet P.J. Lung cancer in never smokers - A review. Eur J Cancer 2012, 48:1299-1311.
10. Thomas J.L., Guo H., Carmella S.G., Balbo S., Han S., Davis A., et al. Metabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homes. Cancer Epidemiol Biomark Prev 2011, 20:1213-1221.
11. Koshiol J., Rotunno M., Gillison M.L., Van Doorn L.J., Chaturvedi A.K., Tarantini L., et al. Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst 2011, 103:501-507.
12. Shiels M.S., Albanes D., Virtamo J., Engels E.A. Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomark Prev 2011, 20:672-678.
13. Darby S., Hill D., Auvinen A., Barros-Dios J.M., Baysson H., Bochicchio F., et al. Radon in homes and risk of lung cancer: Collaborative analysis of individual data from 13 European case-control studies. Br Med J 2005, 330:223-226.
14. Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers-A different disease. Nat Rev Cancer 2007, 7:778-790.
15. Rahman I., Biswas S.K., Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006, 533:222-239.
16. Pryor W.A., Stone K., Cross C.E., Machlin L., Packer L. Oxidants in cigarette smoke: Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993, 686:12-28.
17. Valavanidis A., Vlachogianni T., Fiotakis K. Tobacco smoke: Involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health 2009, 6:445-462.
18. Sarir H., Mortaz E., Janse W.T., Givi M.E., Nijkamp F.P., Folkerts G. IL-8 production by macrophages is synergistically enhanced when cigarette smoke is combined with TNFα. Biochem Pharmacol 2010, 79(5):698-705.
19. Chan H.P., Tran V., Lewis C., Thomas P.S. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol 2009, 4:172-178.
20. Fubini B., Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radical Biol Med 2003, 34:1507-1516.
21. Fubini B., Giamello E., Volante M., Bolis V. Chemical functionalities at the silica surface determining its reactivity when inhaled. Formation and reactivity of surface radicals. Toxicol Ind Health 1990, 6:571-598.
22. Fubini B., Bolis V., Giamello E. The surface chemistry of crushed quartz dust in relation to its pathogenicity. Inorg Chim Acta 1987, 138:193-197.
23. Fubini B., Fenoglio I., Elias Z., Poirot O. Variability of biological responses to silicas: Effect of origin, crystallinity, and state of surface on generation of reactive oxygen species and morphological transformation of mammalian cells. J Environ Pathol, Toxicol Oncol 2001, 20:95-108.
24. Guidotti T.L., Miller A., Christiani D., Harbut M.R., Hillerdal G., Balmes J.R., et al. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004, 170:691-715.
25. Kamp D.W., Graceffa P., Pryor W.A., Weitzman S.A. The role of free radicals in asbestos-induced diseases. Free Radical Biol Med 1992, 12:293-315.
26. Liu G., Beri R., Mueller A., Kamp D.W. Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis. Chem-Biol Interact 2010, 188:309-318.
27. Shuguang L., Dinhua P., Guoxiong W. Analysis of polycyclic aromatic hydrocarbons in cooking oil fumes. Arch Environ Health 1994, 49:119-122.
28. Fu P.P., Xia Q., Sun X., Yu H. Phototoxicity and environmental transformation of polycyclic aromatic hydrocarbons (PAHs)-light-induced reactive oxygen species, lipid peroxidation, and DNA damage. J Environ Sci Health, Part C: Environ Carcinog Ecotoxicol Rev 2012, 30:1-41.
29. Yu H. Environmental carcinogenic polycyclic aromatic hydrocarbons: Photochemistry and phototoxicity. J Environ Sci Health, Part C: Environ Carcinog Ecotoxicol Rev 2002, 20:149-183.
30. Foote C.S. Definition of type I and type II photosensitized oxidation. Photochem Photobiol 1991, 54:659.
31. Sauer H., Wartenberg M., Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 2001, 11:173-186.
32. Emmendoerffer A., Hecht M., Boeker T., Mueller M., Heinrich U. Role of inflammation in chemical-induced lung cancer. Toxicol Lett 2000, 112-113:185-191.
33. Brody J.S., Spira A. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc 2006, 3:535-537.
34. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008, 8:183-192.
35. Drost E.M., Skwarski K.M., Sauleda J., Roca J., Agusti A., MacNee W. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 2005, 60:293-300.
36. Azad N., Rojanasakul Y., Vallyathan V. Inflammation and lung cancer: Roles of reactive oxygen/nitrogen species. J Toxicol Environ Health, Part B 2008, 11:1-15.
37. Zieba M., Suwalski M., Kwiatkowska S., Piasecka G., Grzelewskarzymowska I., Stolarek R., et al. Comparison of hydrogen peroxide generation and the content of lipid peroxidation products in lung cancer tissue and pulmonary parenchyma. Respir Med 2000, 94:800-805.
38. Hecht S.S. Lung carcinogenesis by tobacco smoke. Int J Cancer 2012, 131:2724-2732.
39. Hecht S.S. Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention. Lancet Oncol 2002, 3:461-469.
40. Adcock I.M., Caramori G., Barnes P.J. Chronic Obstructive pulmonary disease and lung cancer: New molecular insights. Respir Int Rev Thoracic Dis 2011, 81:265-284.
41. Feig D.I., Reid T.M., Loeb L.A. Reactive oxygen species in tumorigenesis. Cancer Res 1994, 54. 1890s-4s.
42. Klaunig J.E., Kamendulis L.M. The Role of Oxidative Stress in Carcinogenesis. Annu Rev Pharmacol Toxicol 2004, 44:239-267.
43. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21:361-370.
44. Szab C., Ohshima H. DNA damage induced by peroxynitrite: Subsequent biological effects. Nitric Oxide 1997, 1:373-385.
45. Ai S.S.Y., Hsu K., Cheng Z., Hunt J., Lewis C.R., Thomas P.S. Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer. Respir Med 2013, 18.
46. Dela Cruz C.S., Tanoue L.T., Matthay R.A. Lung Cancer: Epidemiology, Etiology, and Prevention. Clin Chest Med 2011, 32:605-644.
47. Dubey S., Powell C.A. Update in lung cancer 2007. Am J Respir Crit Care Med 2008, 177:941-946.
48. Punturieri A., Szabo E., Croxton T.L., Shapiro S.D., Dubinett S.M. Lung cancer and chronic obstructive pulmonary disease: Needs and opportunities for integrated research. J Natl Cancer Inst 2009, 101:554-559.
49. Belinsky S.A. Role of the cytosine DNA-methyltransferase and p16(INK4a) genes in the development of mouse lung tumors. Exp Lung Res 1998, 24:463-479.
50. Bennett W.P., Colby T.V., Travis W.D., Borkowski A., Jones R.T., Lane D.P., et al. p53 Protein accumulates frequently in early bronchial neoplasia. Cancer Res 1993, 53:4817-4822.
51. Volm M., Van Kaick G., Mattern J. Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases. Clin Exp Metastasis 1994, 12:329-334.
52. Sancar A., Lindsey-Boltz L.A., Ünsal-Kaçmaz K., Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004, 73:39.
53. Nagorni-Obradović L., Pesut D., Skodrić-Trifunović V., Adzić T. Influence of tobacco smoke on the appearance of oxidative stress in patients with lung cancer and chronic obstructive pulmonary diseases. Vojnosanit Pregl 2006, 63:893-895.
54. Kinnula V.L. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 2005, 60:693-700.
55. Lippman S.M., Lee J.J., Karp D.D., Vokes E.E., Benner S.E., Goodman G.E., et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 2001, 93:605-617.
56. Van Zandwijk N., Dalesio O., Pastorino U., De Vries N., Van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. J Natl Cancer Inst 2000, 92:977-986.
57. Cortés-Jofré M., Rueda J.R., Corsini-Muñoz G., Fonseca-Cortés C., Caraballoso M., Bonfill Cosp X. Drugs for preventing lung cancer in healthy people. Cochrane database of systematic reviews (Online) 2012, 10.
58. Group TA-T.B.C.C.P.S. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994, 330:1029-1035.
59. Kelly K., Kittelson J., Franklin W.A., Kennedy T.C., Klein C.E., Keith R.L., et al. A randomized phase II chemoprevention trial of 13-cis retinoic acid with or without α tocopherol or observation in subjects at high risk for lung cancer. Cancer Prev Res 2009, 2:440-449.
60. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996, 334:1150-1155.